In recent years, therapeutic antibodies have transformed the treatment of cancer and autoimmune diseases. Now, researchers at Lund University in Sweden have developed a new, efficient method based on the ‘genetic scissors’ CRISPR-Cas9 that facilitates antibody development. The discovery is published in Nature Communications.